View the Panel above with Wendy Zatylny
In the post-pandemic world, companies worldwide face fragile supply chains, and biotech is no exception. Resilient supply chains are essential to deliver life-saving biotech innovations to patients. They enable all regions to contribute to, and benefit from, global advances in biotechnology. Panelists from national trade associations and companies will explore both national and international viewpoints on supply chain challenges, opportunities, and shared priorities.
Panelists: Claire Skentelbery, Director EuropaBio; Kelly Seagraves, VP for National Security and International Affairs, Bitechnology Innovation Organization; Steven Weisman, Global President, Clinical and Regulatory, Lumanity; Wieteke Wouters, Program Director, HollandBio, and Wendy Zatylny, President & CEO, BIOTECanada.